To lower costs, Trump to force hospitals to reveal price of care

15 November 2019 - The Trump administration on Friday announced it would begin forcing hospitals to publicly disclose the discounted ...

Read more →

Improving transparency in decision models: current issues and potential solutions

23 October 2019 - Decision-analytic models have become an essential tool used to inform health technology assessments. ...

Read more →

NICE, in confidence: an assessment of redaction to obscure confidential information in single technology appraisals by the National Institute for Health and Care Excellence

17 November 2019 - Health technology assessment aims to provide a transparent framework within which normative judgements can be applied for ...

Read more →

Canada's decision to make public more clinical trial data puts pressure on FDA

11 October 2019 - Last March, Canada's department of health changed the way it handles the huge amount of data ...

Read more →

Why transparency in drug pricing is more complicated than it seems

1 October 2019 - Transparency has become a prominent topic in debates about health care, particularly when it comes to ...

Read more →

1 October 2019 price disclosure confirmed prices

30 September 2019 - Confirmed 1 October 2019 prices resulting from the 2019 October Cycle of Price Disclosure have now been ...

Read more →

Achieving appropriate model transparency: challenges and potential solutions for making value‑based decisions in the United States

5 September 2019 - Transparency in decision modeling remains a topic of rigorous debate among healthcare stakeholders, given tensions between the ...

Read more →

What is the value of market-wide health care price transparency?

5 September 2019 - A primary driver of high spending in the US health care system, relative to other countries, ...

Read more →

Capital Rx to inject transparency in prescription drug prices

4 September 2019 - In recent years, the pharmacy benefits management industry's pricing practices have been under intense scrutiny by ...

Read more →

Time for FDA to release complete responses letters? Debate reignites.

23 August 2019 - The idea of the US FDA releasing complete response letters resurfaced this week as Sarepta Therapeutics ...

Read more →

Appealing court ruling, Trump administration renews fight to require drug prices in TV ads

21 August 2019 - The Trump administration isn’t giving up the fight to require drug makers include their sticker prices ...

Read more →

Extension to feedback for public consultation - standardised redactions of PBAC Public Summary Documents

19 August 2019 - On 30 July 2019, the Department of Health held an information forum to provide industry, consumers and ...

Read more →

Lack of transparency hampers cancer drug debate

19 August 2019 - The current debate raging over cancer drug funding is emotional, and the different agenda of lobby ...

Read more →

Insurers snooping in our health records

9 August 2019 - Life insurers have trawled through the medical records of 150,000 Australians in an attempt to deny ...

Read more →

Public consultation – standardised redactions of Public Summary Documents

2 August 2019 - On 30 July 2019, the Department of Health held an information forum to provide industry, consumers ...

Read more →